QDX is redefining the foundations of computational drug discovery: integrating AI, quantum mechanics, and high-performance computing to make simulations dramatically faster, more accurate, and scalable. The team recently became the first to model a system of over one million electrons at the MP2 level of theory - an unprecedented milestone that earned their lead scientist the Dirac Medal. Now, they're working on making this power accessible to everyone.

Through their spinout, Rush, they’re building an AI-driven platform that enables non-computational researchers to easily apply advanced computational tools - lowering barriers, cutting costs, and accelerating breakthroughs.

BIO attendees can try Rush free at rush.cloud/preview.